The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia
<p>Abstract</p> <p>Background</p> <p>The clinical predictors of aromatase inhibitor-related arthralgia (AIA), a drug-related adverse reaction of aromatase inhibitors (AIs), remain unclear.</p> <p>Methods</p> <p>AIA was prospectively surveyed ever...
Main Authors: | Takahashi Masako, Nakagawa Misako, Nagao Taeko, Honda Junko, Morimoto Masami, Kanematsu Miyuki, Tangoku Akira, Sasa Mitsunori |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/436 |
Similar Items
-
Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
by: Junko Honda, et al.
Published: (2011-01-01) -
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
by: Zembutsu Hitoshi, et al.
Published: (2009-11-01) -
Evaluation of Arthralgia Induced by Aromatase Inhibitor Therapy
by: Gulabi Mese, et al.
Published: (2013-02-01) -
Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
by: Sally A.D. Romero, et al.
Published: (2020-02-01) -
A case of matrix-producing carcinoma of the breast
by: Nagao Taeko, et al.
Published: (2008-06-01)